Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health. Alta LS is a bridge fund, connecting both sides of the Atlantic, joining the Spanish life sciences ecosystem with the Venture Capital expertise of Silicon Valley. The management team, led by Guy Nohra*, is headquartered in Barcelona. The remainder of the team is formed by experienced life science professionals from the US and Spain. *Mr. Nohra is co-founder of Alta Partners, a leading pioneer Venture Capital firm in life sciences, funding over 150 companies since 1996. He was named to the 2007 Forbes Midas List of dealmakers in Venture Capital. Altamar Private Equity, SGIIC, SAU is the Fund’s Management Company.
13
Total Investments
9
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Alta Life Sciences
Recent Investments (13)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Late Vc | •••••• | Jan 2022 | |
| Venture Round | •••••• | Oct 2021 | |
| Series E | •••••• | May 2021 | |
| Series A | •••••• | Mar 2021 | |
| Venture Round | •••••• | Jan 2021 | |
|
|
Late Vc | •••••• | Dec 2020 |
|
|
Series A | •••••• | Jun 2020 |
|
|
Seed | •••••• | Jun 2020 |
|
|
Series A | •••••• | May 2020 |
|
|
Series D | •••••• | Jun 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.